Atlantic Health System
atlantichealth.orgLive pipeline data from ClinicalTrials.gov, refreshed daily.
Total trials
62
Active
10
Phase 3
1
Total enrollment
8,124
Pipeline matrix
Showing 5 of 5 active programs · click any cell for trials
| Intervention | Early Phase 1 | Phase 1 | Phase 2 | Phase 3 | Phase 4 | N/A | Total |
|---|---|---|---|---|---|---|---|
| Nitrofurantoin | — | — | — | — | — | 1 | |
| Silodosin 8 mg | — | — | — | — | — | 1 | |
| Vancomycin (VAN) treatment | — | — | — | — | — | 1 | |
| NaF PET-CT | — | — | — | — | — | 1 | |
| Methenamine Hippurate 1g BD | — | — | — | — | — | 1 |
Next readouts
- 2024-08-16
- 2025-06-01
- 2026-12-20
- 2027-07-30
- 2028-03
Top conditions
- Pelvic Organ Prolapse11
- Urinary Incontinence4
- Vaginal Discharge3
- Mesh Erosion2
- Stress Urinary Incontinence2
- Mitral Regurgitation2
- Thromboembolic Stroke1
- Familial Hypercholesterolemia1
Frequently asked questions about Atlantic Health System
- How many clinical trials does Atlantic Health System have on ClinicalTrials.gov?
- Atlantic Health System is listed as the lead sponsor on 62 clinical trials in ClinicalTrials.gov, 10 of which are currently active (recruiting, enrolling, or ongoing).
- How many of Atlantic Health System's trials are in Phase 3?
- 1 of Atlantic Health System's trials are in Phase 3, spread across 5 active drug programs.
- What therapeutic areas does Atlantic Health System focus on?
- Atlantic Health System's most-studied conditions on ClinicalTrials.gov are Pelvic Organ Prolapse, Urinary Incontinence, Vaginal Discharge, Mesh Erosion, Stress Urinary Incontinence.
- When are Atlantic Health System's next clinical trial readouts?
- Atlantic Health System has 5 upcoming primary-completion readouts tracked here; the soonest is “Use of Prophylactic Antibiotics Prior to OnabotulinumtoxinA”, expected around 2024-08-16.